JP Morgan 2023 – Claudia Ulbrich
On Wednesday of JP Morgan week last month, pharmaphorum editor-in-chief Jonah Comstock sat down at the Zeppelin Hotel with Claudia Ulbrich, CEO of Germany-based Cardior, to learn a little more about her company and her experience at the show.
Cardior is a clinical-stage biopharmaceutical company exploring the applications of non-coding RNA-based drugs in cardiovascular disease, on a mission to prevent and reverse cardiac disfunction using this novel therapeutic category, which is able to address multi-focal pathways to disease treatment.
Jonah and Claudia discuss Cardior’s plans, the importance of novel therapeutic options, surviving a conservative funding market, and why small pharmas should be flexible in their future plans when it comes to acquisition.
Watch the interview below and stay tuned for more videos from JP Morgan 2023.